Lara Traeger
Overview
Explore the profile of Lara Traeger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
2277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El-Jawahri A, Reese J, Traeger L, Dizon D, Cutler C, Bober S, et al.
J Natl Compr Canc Netw
. 2025 Feb;
23(2).
PMID: 39938468
Background: Interventions to address sexual health in hematopoietic stem cell transplant (HSCT) survivors are limited. Methods: We conducted a pilot randomized trial of a digital app, SHIFT (Sexual Health and...
2.
Centracchio J, Yang D, Jagielo A, Greer J, El-Jawahri A, Traeger L, et al.
Support Care Cancer
. 2025 Jan;
33(2):102.
PMID: 39814942
Purpose: Chronic graft-versus-host-disease (cGVHD), an inflammatory condition affecting allogeneic hematopoietic cell transplantation (HCT) survivors, is associated with a range of debilitating physical and psychological sequela. Yet HCT recipients with cGVHD...
3.
Post K, Aribindi S, Traeger L, Hall D, Jacobs J, Temel J, et al.
Support Care Cancer
. 2024 Dec;
33(1):18.
PMID: 39663232
Purpose: Patients with triple-negative breast cancer (TNBC) are at high risk for breast cancer recurrence and metastatic disease, yet the scholarly literature on the distress and uncertainty of this vulnerable...
4.
Falade A, Boulanger M, Hsu K, Sarathy R, Fadden R, Reynolds K, et al.
Support Care Cancer
. 2024 Sep;
32(10):684.
PMID: 39320566
Background/objective: Immune checkpoint inhibitors (ICIs) have revolutionized treatment for melanoma and lung cancer and are in widespread use. This study aims to describe how patients and caregivers learn about ICI...
5.
Lage D, Burger A, Cohn J, Hernand M, Jin E, Horick N, et al.
J Pain Symptom Manage
. 2024 Aug;
68(6):613-621.e1.
PMID: 39197695
Context: Patients with advanced cancer are at increased risk for multiple hospitalizations and often have considerable needs postdischarge. Interventions to address patients' needs after transitioning home are lacking. Objectives: We...
6.
Newcomb R, Traeger L, Jones B, Reynolds M, Tse A, Reese J, et al.
Transplant Cell Ther
. 2024 Aug;
30(11):1106.e1-1106.e13.
PMID: 39181537
Hematopoietic stem cell transplant (HSCT) survivors frequently experience persistent sexual dysfunction, which is associated with impaired quality of life and increased psychological distress. The lack of availability of clinicians with...
7.
Boulanger M, Falade A, Hsu K, Sommer R, Zhou A, Sarathy R, et al.
JCO Oncol Pract
. 2024 Jul;
21(2):178-187.
PMID: 39038253
Purpose: Immunotherapy has improved survival for patients with melanoma and non-small cell lung cancer (NSCLC). Yet, as responses vary widely, immunotherapy also introduces challenges in prognostic communication. In this study,...
8.
Falade A, Boulanger M, Hsu K, Sarathy R, Fadden R, Reynolds K, et al.
Res Sq
. 2024 Jul;
PMID: 39011099
Background/objective: Immune checkpoint inhibitors (ICIs) have revolutionized treatment for melanoma and lung cancer and are in widespread use. This study aims to describe how patients and caregivers learn about ICI...
9.
Kamdar M, Jethwani K, Centi A, Agboola S, Fischer N, Traeger L, et al.
J Pain Symptom Manage
. 2024 Jun;
68(3):261-271.
PMID: 38866116
Background: Patients with advanced cancer often experience immense cancer pain that negatively impacts their quality of life. Interventions to address cancer-related pain are limited. Methods: We conducted a randomized trial...
10.
Nelson A, Yang D, Jagielo A, DAlotto J, Poliquin C, Rabideau D, et al.
J Natl Compr Canc Netw
. 2024 Feb;
22(1):34-42.
PMID: 38394783
Background: More than half the long-term survivors of allogeneic hematopoietic cell transplantation develop chronic graft-versus-host disease (GVHD), a debilitating inflammatory syndrome. Supportive interventions to assist survivors in coping with chronic...